Loading...
Loading...
Among the 5 tracked institutional investors we monitor, GANX (GAIN THERAPEUTICS INC) is held with a combined value of $4.95M across 1,745,329 shares. The largest holder is GREENLIGHT CAPITAL INC with a position worth $1.92M (0.09% of their portfolio). 3 funds increased their holdings.
Total Institutional Value
$4.95M
Total Shares Held
1,745,329
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | GREENLIGHT CAPITAL INC | $1.92M | 0.09% | - |
| 2 | VANGUARD GROUP INC | $1.84M | 0.00% | +6.7% |
| 3 | BlackRock, Inc. | $558.16K | 0.00% | +22.2% |
| 4 | STATE STREET CORP | $319.80K | 0.00% | - |
| 5 | CITADEL ADVISORS LLC | $313.68K | 0.00% | +520.6% |
As of the latest SEC 13F filings, GREENLIGHT CAPITAL INC is the largest institutional holder of GANX with a position worth $1.92M, representing 0.09% of their portfolio. In total, 5 institutional investors hold GANX with a combined value of $4.95M.
Institutional investors hold $4.95M worth of GANX stock across 5 positions. The largest institutional holder is GREENLIGHT CAPITAL INC with $1.92M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GANX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GANX positions.
Last Close
$1.19
2026-10-21
YTD
-62.6%
0% of 52-week range